Beximco Pharmaceuticals Limited
BXP.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$24.09B
Close$
Share Statistics
| Market cap | $24.09 Billion |
|---|---|
| Enterprise Value | $22.99 Billion |
| Dividend Yield | $2.32 (4.50%) |
| Earnings per Share | $15.56 |
| Beta | 0.25 |
| Outstanding Shares | 446,112,089 |
Return
| Return on Equity | 14.51% |
|---|---|
| Return on Assets | 11.06% |
| Return on Invested Capital | 15.80% |
Valuation & Multiples
| P/E Ratio | 4.37 |
|---|---|
| PEG | 17.58 |
| Price to Sales | 0.45 |
| Price to Book Ratio | 0.38 |
| Enterprise Value to Revenue | -0.02 |
| Enterprise Value to EBIT | -0.08 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -3.57 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Beximco Pharmaceuticals Limited
6,000 employees
CEO: Iqbal U. Ahmed Established in 1976 and headquartered in Dhaka, Bangladesh, Beximco Pharmaceuticals Limited is a prominent company engaged in the production and distribution of generic pharmaceutical formulations and active pharmaceutical ingredients (A...